viewIndivior PLC

Indivior facing £1bn claim from former parent Reckitt Benckiser

Indivior has been dogged by lawsuits over its opioid dependency treatment suboxone ever since the demerger.

Reckitt Benckiser -

Indivior PLC (LON:INDV) said former parent Reckitt Benckiser PLC (LON:RB.) has filed a claim for more than £1bn under an indemnity signed in 2014 when the two demerged.

The amount in the writ is a little over £1.073bn and Invidior said it will assess its merits with advisors though it added that as yet the claim had not been served on the company.

Indivior has been dogged by lawsuits over its opioid dependency treatment Suboxone ever since the demerger.

The group has been fighting off generic competitors claiming its patent has run out, while also battling multiple legal actions over how the drug was marketed.

In October, former chief executive Shaun Thaxter was sentenced to six months in prison and ordered to pay US$0.6mln in fines.

Thaxter “failed to prevent efforts to build profits through misleading safety claims, which led to millions of dollars in ill-gotten gains for Indivior”, the US Attorney Daniel P Bubar said.

Indivior had earlier agreed to pay US$600mln to the US Department of Justice, the Federal Trade Commission (FTC) and various state attorneys general as part of a settlement over the way Suboxone was marketed.

A year earlier Reckitt Benckiser agreed to pay around US$1.4bn to the US authorities in an effort to draw a line under the issue.

That settlement related to a Department of Justice investigation which accused Indivior of illegally boosting prescriptions of Suboxone.

An indictment claimed Indivior had marketed its star drug as safer and less abusable than other treatments, deceiving healthcare providers and allowing the company to rake in billions of dollars in extra sales.

It was also accused of pushing patients towards doctors who it knew were prescribing opioids “at high rates and in a clinically unwarranted manner”.

Reckitt denied the allegations but said it had settled the claims to avoid further litigation and uncertainty.

Shares in Indivor tumbled 40% to 75.7p valuing the group at £560mln. Reckitt dropped 1% to 6,520p.

Quick facts: Indivior PLC

Price: 130.1675 GBX

Market: LSE
Market Cap: £950.79 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...


Genel Energy now more ambitious and ready to grow in 2021, after 'building...

Genel Energy PLC's (LON:GENL), Bill Higgs speaks to Proactive London about their latest trading and operational result. Higgs explains how 2020, despite being a tough year, 'set the foundation for what's ahead', and now in a position to grow in 2021, with a twelve-well drill campaign among...

3 hours, 1 minute ago

2 min read